| MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients MP Wattjes, À Rovira, D Miller, TA Yousry, MP Sormani, N De Stefano, ... Nature Reviews Neurology 11 (10), 597-607, 2015 | 554 | 2015 |
| Injectable hydrogel-based drug delivery systems for local cancer therapy M Norouzi, B Nazari, DW Miller Drug discovery today 21 (11), 1835-1849, 2016 | 455 | 2016 |
| Pluronic® block copolymers as modulators of drug efflux transporter activity in the blood–brain barrier AV Kabanov, EV Batrakova, DW Miller Advanced drug delivery reviews 55 (1), 151-164, 2003 | 395 | 2003 |
| Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization EV Batrakova, S Li, SV Vinogradov, VY Alakhov, DW Miller, AV Kabanov Journal of Pharmacology and Experimental Therapeutics 299 (2), 483-493, 2001 | 381 | 2001 |
| Detection of single atoms and buried defects in three dimensions by aberration-corrected electron microscope with 0.5-Å information limit C Kisielowski, B Freitag, M Bischoff, H Van Lin, S Lazar, G Knippels, ... Microscopy and Microanalysis 14 (5), 469-477, 2008 | 379 | 2008 |
| Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells RW Mitchell, NH On, MR Del Bigio, DW Miller, GM Hatch Journal of neurochemistry 117 (4), 735-746, 2011 | 331 | 2011 |
| Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells EV Batrakova, S Li, VY Alakhov, DW Miller, AV Kabanov Journal of Pharmacology and Experimental Therapeutics 304 (2), 845-854, 2003 | 325 | 2003 |
| Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region X Li, Y Li, H Han, DW Miller, G Wang Journal of the American Chemical Society 128 (17), 5776-5785, 2006 | 322 | 2006 |
| Measurement of small-angle antiproton-proton and proton-proton elastic scattering at the CERN intersecting storage rings N Amos, MM Block, GJ Bobbink, M Botje, D Favart, C Leroy, F Linde, ... Nuclear Physics B 262 (4), 689-714, 1985 | 307 | 1985 |
| Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion EV Batrakova, S Li, WF Elmquist, DW Miller, VY Alakhov, AV Kabanov British journal of cancer 85 (12), 1987-1997, 2001 | 289 | 2001 |
| Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells Y Zhang, H Han, WF Elmquist, DW Miller Brain research 876 (1-2), 148-153, 2000 | 284 | 2000 |
| Tumor necrosis factor-α induces cyclooxygenase-2 expression and prostaglandin release in brain microvessel endothelial cells KS Mark, WJ Trickler, DW Miller Journal of Pharmacology and Experimental Therapeutics 297 (3), 1051-1058, 2001 | 264 | 2001 |
| Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers EV Batrakova, S Li, DW Miller, AV Kabanov Pharmaceutical research 16, 1366-1372, 1999 | 263 | 1999 |
| Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells H Huai-Yun, DT Secrest, KS Mark, D Carney, C Brandquist, WF Elmquist, ... Biochemical and biophysical research communications 243 (3), 816-820, 1998 | 263 | 1998 |
| Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies EV Batrakova, DW Miller, SHU Li, VY Alakhov, AV Kabanov, WF Elmquist Journal of Pharmacology and Experimental Therapeutics 296 (2), 551-557, 2001 | 246 | 2001 |
| Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption DW Miller, EV Batrakova, TO Waltner, VY Alakhov, AV Kabanov Bioconjugate chemistry 8 (5), 649-657, 1997 | 228 | 1997 |
| The use of TKM-100802 and convalescent plasma in 2 patients with Ebola virus disease in the United States CS Kraft, AL Hewlett, S Koepsell, AM Winkler, CJ Kratochvil, LA Larson, ... Clinical infectious diseases 61 (4), 496-502, 2015 | 223 | 2015 |
| Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis T Moreau, N Scolding, A Compston, J Thorpe, D Miller, I Moseley, G Hale, ... The Lancet 344 (8918), 298-301, 1994 | 219 | 1994 |
| Plasma membrane localization of multidrug resistance-associated protein homologs in brain capillary endothelial cells Y Zhang, JD Schuetz, WF Elmquist, DW Miller Journal of Pharmacology and Experimental Therapeutics 311 (2), 449-455, 2004 | 211 | 2004 |
| Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis ML Baier, GR Cutter, RA Rudick, D Miller, JA Cohen, ... Neurology 64 (6), 992-995, 2005 | 206 | 2005 |
